Survey Study for Pain Management, Wound Care, Scar Care or UDT

Study Overview
=================
Brief Summary
-----------------
This is a survey study that will be given to patients who have been prescribed a topical compound for pain management, wound care or scar care or to patients who have been requested to do a urinary drug test (UDT) by their provider. The initial survey for pain management, wound care, scar care or UDT will be given to the patient by their providers during their office visit.

Detailed Description
-----------------
We have designed a survey study that will be given to patients who have been prescribed a topical compound for pain management, wound care or scar care or to patients who have been requested to do a urinary drug test (UDT) by their provider. The initial survey for pain management, wound care, scar care or UDT will be given to the patient by their providers during their office visit. Follow-up surveys will be given at 30, 60, and 90 days. These surveys will be collected by e-mail or follow-up calls from Datum Research, LLC, contract research organization. Data collection for this study will be derived through the 4 patient surveys (initial, 30 day, 60 day, and 90 day) and the prescription written by the provider. The survey study will enroll patients until December 31, 2014, or until sufficient numbers have been achieved. Rahm Foundation will continue the study until: Sufficient information has accumulated to meet the scientific objectives of the Study (i.e. numeric targets or effect size) The feasibility of collecting sufficient information diminishes to unacceptable levels, poor enrollment, loss to follow-up and/or Other methods of gathering appropriate information become achievable or are deemed preferable. Datum Research will need to have access to the prescription to see what compound was prescribed.

Official Title
-----------------
Survey of Patients Who Have Been Prescribed a Topical Compound for Pain Management, Wound Care or Scar Care or to Patients Who Have Been Requested to do a Urinary Drug Test (UDT) by Their Provider.

Conditions
-----------------
Pain, Scars, Wounds, Urinary Drug Testing

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Prescribed a topical cream for pain, scar care, or wound OR Provider preforms urinary drug test Exclusion Criteria: Subjects with legally authorized representatives Minors Prisoners

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Pain management<br>patients undergoing transdermal treatment for pain | |
| Scar care<br>patients undergoing transdermal treatment for scars | |
| Wound care<br>patients undergoing transdermal treatment for wounds | |
| UDT<br>patients receiving urinary drug tests | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in pain survey results from baseline at 30 days | Survey on pain management | baseline and 30 days | 
| Change in pain survey results from baseline at 60 days | Survey on pain management | baseline and 60 days | 
| Change in pain survey results from baseline at 90 days | Survey on pain management | baseline and 90 days | 
| Change in scar care survey results from baseline at 30 days | Survey on scar care | baseline and 30 days | 
| Change in scar care survey results from baseline at 60 days | Survey on scar care | baseline and 60 days | 
| Change in scar care survey results from baseline at 90 days | Survey on scar care | baseline and 90 days | 
| Change in wound care survey results from baseline at 30 days | Survey on wound care | baseline and 30 days | 
| Change in wound care survey results from baseline at 60 days | Survey on wound care | baseline and 60 days | 
| Change in wound care survey results from baseline at 90 days | Survey on wound care | baseline and 90 days | 
| Change in UDT survey results from baseline at 30 days | Survey on urinary drug testing | baseline and 30 days | 
| Change in UDT survey results from baseline at 60 days | Survey on urinary drug testing | baseline and 60 days | 
| Change in UDT survey results from baseline at 90 days | Survey on urinary drug testing | baseline and 90 days | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in pain survey results from 30 days at 60 days | Survey on pain management | 30 days and 60 days | 
| Change in pain survey results from 30 days at 90 days | Survey on pain management | 30 days and 90 days | 
| Change in pain survey results from 60 days at 90 days | Survey on pain management | 60 days and 90 days | 
| Length of hospital stay | if applicable | at baseline | 
| Change in scar care survey results from 30 days at 60 days | Survey on scar care | 30 days and 60 days | 
| Change in scar care survey results from 30 days at 90 days | Survey on scar care | 30 days and 90 days | 
| Change in scar care survey results from 60 days at 90 days | Survey on scar care | 60 days and 90 days | 
| Change in wound care survey results from 30 days at 60 days | Survey on wound care | 30 days and 60 days | 
| Change in wound care survey results from 30 days at 90 days | Survey on wound care | 30 days and 90 days | 
| Change in UDT survey results from 60 days at 90 days | Survey on urinary drug testing | 60 days and 90 days | 
| Change in UDT survey results from 30 days at 60 days | Survey on urinary drug testing | 30 days and 60 days | 
| Change in UDT survey results from 30 days at 90 days | Survey on urinary drug testing | 30 days and 90 days | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Pain management, Scar care, Wound care, UDT, Urinary drug testing